About this release

This annual release by Public Health Scotland (PHS) reports on the prescribing of long acting reversible methods of contraception (LARC) in primary care and sexual health settings in Scotland. This includes the contraceptive implant, intrauterine device (IUD) and intrauterine system (IUS). Contraceptive injections are also reported on but are presented separately. These data are based on the NHS board of prescription.

Main points

In primary care and sexual health settings combined in 2024/25:

  • The LARC prescribing rate decreased from 47.4 to 46.6 per 1,000 women between 2023/24 and 2024/25. This is lower than rates before the Covid-19 pandemic.
Image caption LARC prescribing rate by type of LARC
  • The contraceptive implant was the most common type of LARC prescribed in 2024/25 with rates of 21.1 per 1,000 women, a rise from 20.1 in 2023/24. The rates for IUS were 19.2 per 1,000 women, a decrease from 21.0 and the rates for IUD decreased from 6.4 to 6.3.
  • The rate for prescribing of contraceptive injections was 22.5 in 2024/25 a decrease from 23.6 in 2023/24.
  • There is variation in LARC prescribing across health board areas. Differences in the ages of patients living within the board areas and/or patients living in one area but accessing services in another may contribute to this variation.
  • There is variation in LARC prescribing rates across age groups. However, it should be noted that in 16% of prescriptions we do not know the patient's age which may mean that variation by age is less or more than it appears to be.

Background

In typical use, the long acting methods of contraception can have a lower failure rate than alternative reversible methods such as the contraceptive pill or condoms. In September 2015 the Sexual Health and Blood Borne Virus Framework 2015-2020 Update was published. In August 2021, Reset and Rebuild: A Recovery Plan for Sexual Health and Blood Borne Virus Services was released, detailing the impacts of the Covid-19 pandemic on sexual health and blood borne virus services in Scotland. In 2023 the Sexual health and blood borne virus action plan (2023-2026) was published. Increasing the availability of LARC is also one of the aims of the Scottish Government's Women's Health Plan which seeks to drive forward change and improvement in women's health.

Further information

The next release of this publication will be September 2026.

General enquiries

If you have an enquiry relating to this publication, please contact Duncan McMaster at phs.maternitystats@phs.scot.

Media enquiries

If you have a media enquiry relating to this publication, please contact the Communications and Engagement team.

Requesting other formats and reporting issues

If you require publications or documents in other formats, please email phs.otherformats@phs.scot.

To report any issues with a publication, please email phs.generalpublications@phs.scot.

Older versions of this publication

Versions of this publication released before 16 March 2020 may be found on the Data and Intelligence, Health Protection Scotland or Improving Health websites.

Last updated: 15 September 2025
Was this page helpful?